Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Clinical Outcomes Study of the Nexel Total Elbow
NCT02469662 · View on ClinicalTrials.gov ↗
Study Summary
The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.
Conditions Studied
Interventions
- DEVICE Nexel Total Elbow
Study Locations (11)
Other
- Coxa Hospital — Tampere
- Hôpital Purpan (Centre Hospitalier Universitaire Toulouse) — Toulouse
- Arcus Sportklinik — Pforzheim
- AO Mauriziano — Torino
- Amphia Ziekenhuis Breda — Breda
- Wrightington — Wigan
Colorado
- Panorama Orthopedics and Spine Center — Golden
North Carolina
- OrthoCarolina Research Institute — Charlotte
Pennsylvania
- Rothman Institute — Philadelphia
Tennessee
- Campbell Clinic — Germantown
New South Wales
- Sydney Shoulder & Elbow, NSW — Sydney
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2015-06 |
| Est. Completion | 2036-12 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02469662
The ClinicalTrials.gov registry entry for NCT02469662 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 102 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 10 conditions, with Post-traumatic Arthritis appearing as the primary indexed condition, and to 1 intervention — of which Nexel Total Elbow is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02469662 reports 11 study locations spanning 6 distinct geographic areas — top geographies include Other, Colorado, North Carolina. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02469662 about?
NCT02469662 is a clinical study titled "Clinical Outcomes Study of the Nexel Total Elbow". The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.
What is the current status of trial NCT02469662?
This trial is currently recruiting. It is a NA study. The enrollment target is 134 participants. The study started on 2015-06. Estimated completion is 2036-12.
What conditions does trial NCT02469662 study?
This clinical trial studies the following conditions: Post-traumatic Arthritis, Degenerative Arthritis, Elbow Joint Destruction, Post-traumatic Lesions, Ankylosed Joints. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT02469662?
The interventions under investigation include: Nexel Total Elbow (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT02469662?
This trial is sponsored by Zimmer Biomet, which has 102 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02469662 being conducted?
This trial has 11 study locations across Colorado, North Carolina, Pennsylvania, Tennessee, New South Wales. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.